The National Burden of Colorectal Cancer in the United States from 1990 to 2019
- PMID: 38201632
- PMCID: PMC10778178
- DOI: 10.3390/cancers16010205
The National Burden of Colorectal Cancer in the United States from 1990 to 2019
Abstract
CRC accounts for approximately a tenth of all cancer cases and deaths in the US. Due to large differences in demographics among the different states, we aim to determine trends in the CRC epidemiology and across different states, age groups, and genders. CRC rates, age-adjusted to the standard US population, were obtained from the GBD 2019 database. Time trends were estimated as annual percentage change (APC). A pairwise comparison was conducted between age- and gender-specific trends using the tests of parallelism and coincidence. Age-specific trends were also assessed in two age subgroups: younger adults aged 15-49 years and older adults aged 50-74 years. We also analyzed the prevalence, incidence, mortality, and DALYs in the US between 1990 and 2019. A total of 5.53 million patients were diagnosed with CRC in the US between 1990 and 2019. Overall, CRC incidence rates have significantly increased in younger adults (11.1 per 100,000 persons) and decreased in older adults (136.8 per 100,000 persons) (AAPC = 1.2 vs. -0.6; AAPC difference = 1.8, p < 0.001). Age-specific trends were neither identical (p < 0.001) nor parallel (p < 0.001), suggesting that CRC incidence rates are different and increasing at a greater rate in younger adults compared to older adults. However, for both men and women (49.4 and 35.2 per 100,000 persons), incidence rates have decreased over the past three decades at the same rate (AAPC = -0.5 vs. -0.5; AAPC difference = 0, p = 0.1). Geographically, the southern states had the highest mortality rates with Mississippi having the highest rate of 20.1 cases per 100,000 population in 2019. Massachusetts, New York, and the District of Colombia had the greatest decreases in mortality over the study period (-42.1%, -41.4%, and -40.9%). Decreased mortality was found in all states except Mississippi, where the mortality of CRC increased over the study period (+1.5%). This research provides crucial insights for policymakers to tailor resource allocation, emphasizing the dynamic nature of CRC burden across states and age groups, ultimately informing targeted strategies for prevention and intervention.
Keywords: colon cancer; colorectal cancer; epidemiology; health disparity; trends.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures






Similar articles
-
Geographical Variations in Early Onset Colorectal Cancer in the United States between 2001 and 2020.Cancers (Basel). 2024 May 1;16(9):1765. doi: 10.3390/cancers16091765. Cancers (Basel). 2024. PMID: 38730717 Free PMC article.
-
[Disease burden of colorectal cancer in China: any changes in recent years?].Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1633-1642. doi: 10.3760/cma.j.cn112338-20200306-00273. Zhonghua Liu Xing Bing Xue Za Zhi. 2020. PMID: 33297619 Chinese.
-
The Incidence of Rectal Neuroendocrine Tumors Is Increasing in Younger Adults in the US, 2001-2020.Cancers (Basel). 2023 Nov 4;15(21):5286. doi: 10.3390/cancers15215286. Cancers (Basel). 2023. PMID: 37958459 Free PMC article.
-
Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in women of childbearing age from 1990 to 2019.Autoimmun Rev. 2023 Nov;22(11):103450. doi: 10.1016/j.autrev.2023.103450. Epub 2023 Sep 21. Autoimmun Rev. 2023. PMID: 37741529 Review.
-
Mortality Trends in Alzheimer's Disease in Mississippi, 2011-2021.Diseases. 2023 Dec 11;11(4):179. doi: 10.3390/diseases11040179. Diseases. 2023. PMID: 38131985 Free PMC article. Review.
Cited by
-
Disparities in Colorectal Cancer Incidence in the United States, 2000-2019.Gastro Hep Adv. 2024 Jan 19;3(4):562-564. doi: 10.1016/j.gastha.2024.01.004. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39131713 Free PMC article. Review. No abstract available.
-
Efficacy and safety of oral sulfate solution versus polyethylene glycol for colonoscopy: A systematic review and meta-analysis of randomized controlled trials.DEN Open. 2025 Apr 16;5(1):e70113. doi: 10.1002/deo2.70113. eCollection 2025 Apr. DEN Open. 2025. PMID: 40248440 Free PMC article. Review.
-
Gut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives.Cancers (Basel). 2025 Jul 10;17(14):2294. doi: 10.3390/cancers17142294. Cancers (Basel). 2025. PMID: 40723178 Free PMC article. Review.
-
Evaluation of the Relationship Between Nitrate Use and the Prevalence of Colorectal Cancers in the United States.Cureus. 2025 May 21;17(5):e84530. doi: 10.7759/cureus.84530. eCollection 2025 May. Cureus. 2025. PMID: 40546631 Free PMC article.
-
A CLRN3-Based CD8+ T-Related Gene Signature Predicts Prognosis and Immunotherapy Response in Colorectal Cancer.Biomolecules. 2024 Jul 24;14(8):891. doi: 10.3390/biom14080891. Biomolecules. 2024. PMID: 39199281 Free PMC article.
References
-
- Barbirou M., Woldu H.G., Sghaier I., Bedoui S.A., Mokrani A., Aami R., Mezlini A., Yacoubi-Loueslati B., Tonellato P.J., Bouhaouala-Zahar B. Western influenced lifestyle and Kv2.1 association as predicted biomarkers for Tunisian colorectal cancer. BMC Cancer. 2020;20:1086. doi: 10.1186/s12885-020-07605-7. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous